Skip to main content
SpringerLink
Log in

Mood Disturbance in ADHD Due to a General Medical Condition

  • Chapter
  • First Online:
Moodiness in ADHD

Abstract

In this chapter we review methodological approaches to develop a differential diagnosis and to evaluate organic causes of mood disturbance in patients with ADHD, while placing a particular focus on the pediatric population. Many individuals with ADHD experience difficulty with mood disturbance during the course of their illness, making thorough evaluation an important clinical issue. For example, in one population study of 5326 youths with ADHD by Stringaris et al., 38% experienced mood lability, a high percentage that is approximately ten times population rates. In another study by Riley et al. involving 1500 parents of children 6–18 years of age, impairment related to emotional dysregulation in ADHD greatly impacted quality of life, more so than even the attention and hyperactivity deficits themselves. Since practically all psychiatric symptoms can be mimicked by a general medical condition, we explicate the mnemonic MEND A MIND as a useful tool for aiding the clinician at the point of care in formulating a broad differential for organic causes of mood disturbance in patients with ADHD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Venes D. Cyclopedic medical dictionary. Philadelphia: FA Davis Co.; 2005.

    Google Scholar 

  2. Cole PM, Michel MK, Teti LO. The development of emotion regulation and dysregulation: a clinical perspective. Monogr Soc Res Child Dev. 1994;59(2/3):73–100.

    Article  CAS  PubMed  Google Scholar 

  3. Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion-regulation strategies across psychopathology: a meta-analytic review. Clin Psychol Rev. 2010;30(2):217–37.

    Article  PubMed  Google Scholar 

  4. Stringaris A, Cohen P, Pine DS, Leibenluft E. Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry. 2009;166(9):1048–54.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Stringaris A. Irritability in children and adolescents: a challenge for DSM-5. Eur Child Adolesc Psychiatry. 2011;20(2):61–6.

    Article  PubMed  Google Scholar 

  6. Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. Am J Psychiatry. 2003;160(3):430–7.

    Article  PubMed  Google Scholar 

  7. Cosci F, Fava GA, Sonino N. Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom. 2014;84(1):22–9.

    Article  PubMed  Google Scholar 

  8. Zardawi IM. Phaeochromocytoma masquerading as anxiety and depression. Am J Case Rep. 2013;14:161–3.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kantorovich V, Eisenhofer G, Pacak K. Pheochromocytoma. Ann N Y Acad Sci. 2008;1148(1):462–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Arnold BM, Casal G, Higgins HP. Apathetic thyrotoxicosis. Can Med Assoc J. 1974;111(9):957.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Swedo SE, Leonard HL, Casey BJ, Mannheim GB, Lenane MC, Rettew DC, et al. Sydenham’s chorea: physical and psychological symptoms of St Vitus dance. Pediatrics. 1993;91(4):706–13.

    CAS  PubMed  Google Scholar 

  12. Tufan AE, Bilici R, Usta G, Erdoğan A. Mood disorder with mixed, psychotic features due to vitamin b12 deficiency in an adolescent: case report. Child Adolesc Psychiatry Ment Health. 2012;6(1):25.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Halstead ME, Walter KD. Sport-related concussion in children and adolescents. Pediatrics. 2010;126(3):597–615.

    Article  PubMed  Google Scholar 

  14. Chandran L, Cataldo R. Lead poisoning: basics and new developments. Pediatr Rev. 2010;31(10):399–406.

    Article  PubMed  Google Scholar 

  15. Barry PD. Mental health & mental illness. Philadelphia: Lippincott Williams & Wilkins; 2002.

    Google Scholar 

  16. Maggio AB, Martin XE, Gasser CS, Gal-Duding C, Beghetti M, Farpour-Lambert NJ, et al. Medical and non-medical complications among children and adolescents with excessive body weight. BMC Pediatr. 2014;14(1):232.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents. Diabetes Care. 2006;29(5):1150–9.

    Article  PubMed  Google Scholar 

  18. Kaplan MM. Clinical perspectives in the diagnosis of thyroid disease. Clin Chem. 1999;45(8):1377–83.

    CAS  PubMed  Google Scholar 

  19. De Luca F, Santucci S, Corica D, Pitrolo E, Romeo M, Aversa T. Hashimoto’s thyroiditis in childhood: presentation modes and evolution over time. Ital J Pediatr. 2013;39(1):8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tschudy MM, Arcara KM. The Harriet Lane handbook: a manual for pediatric house officers. Philadelphia: Mosby Elsevier; 2012. p. 284–6.

    Google Scholar 

  21. O’Donovan DK. The diagnosis of chronic latent tetany in adults. Irish J Med Sci (1926–1967). 1945;20(5):146–53.

    Article  Google Scholar 

  22. Rothrock SG, Green SM, McArthur CL, DelDuca K. Detection of electrolyte abnormalities in children presenting to the emergency department: a multicenter, prospective analysis. Acad Emerg Med. 1997;4(11):1025–31.

    Article  CAS  PubMed  Google Scholar 

  23. Urschitz MS, Eitner S, Wolff J, Guenther A, Urschitz-Duprat PM, Schlaud M, et al. Risk factors for sleep-related hypoxia in primary school children. Pediatr Pulmonol. 2007;42(9):805–12.

    Article  PubMed  Google Scholar 

  24. Carno MA, Modrak J, Short R, Ellis ER, Connolly HV. Sleep associated gas exchange abnormalities in children and adolescents with habitual snoring. Pediatr Pulmonol. 2009;44(4):364–72.

    Article  PubMed  Google Scholar 

  25. Nieman LK, Turner ML. Addison's disease. Clin Dermatol. 2006;24(4):276–80.

    Article  PubMed  Google Scholar 

  26. Lah S, Castles A, Smith ML. Reading in children with temporal lobe epilepsy: a systematic review. Epilepsy Behav. 2017;68:84–94.

    Article  PubMed  Google Scholar 

  27. Smith ML, Lah S. One declarative memory system or two? The relationship between episodic and semantic memory in children with temporal lobe epilepsy. Neuropsychology. 2011;25(5):634.

    Article  PubMed  Google Scholar 

  28. Gascoigne MB, Smith ML, Barton B, Webster R, Gill D, Lah S. Accelerated long-term forgetting in children with temporal lobe epilepsy. Neuropsychologia. 2014;59:93–102.

    Article  PubMed  Google Scholar 

  29. Martin CB, Mirsattari SM, Pruessner JC, Pietrantonio S, Burneo JG, Hayman-Abello B, Köhler S. Déjà vu in unilateral temporal-lobe epilepsy is associated with selective familiarity impairments on experimental tasks of recognition memory. Neuropsychologia. 2012;50(13):2981–91.

    Article  PubMed  Google Scholar 

  30. Dobrovoljac M, Hengartner H, Boltshauser E, Grotzer MA. Delay in the diagnosis of paediatric brain tumours. Eur J Pediatr. 2002;161(12):663–7.

    Article  PubMed  Google Scholar 

  31. Fragkandrea IO, Nixon JA, Panagopoulou P. Signs and symptoms of childhood cancer: a guide for early recognition. Bone. 2013;100(5):12.

    Google Scholar 

  32. Crawford J. Childhood brain tumors. Pediatrics in review. Am Acad Pediatr. 2013;34(2):63.

    Article  Google Scholar 

  33. Corrigan JJ, Feig SA. Guidelines for pediatric cancer centers. Pediatrics. 2004;113(6):1833–5.

    Article  PubMed  Google Scholar 

  34. Offidani E, Fava GA, Tomba E, Baldessarini RJ. Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom. 2013;82(3):132–41.

    Article  PubMed  Google Scholar 

  35. Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014;348:g1626.

    Article  PubMed  Google Scholar 

  36. Tarter RE, Blackson T, Brigham J, Moss H, Caprara GV. The association between childhood irritability and liability to substance use in early adolescence: a 2-year follow-up study of boys at risk for substance abuse. Drug Alcohol Depend. 1995;39(3):253–61.

    Article  CAS  PubMed  Google Scholar 

  37. Johnson BA, Cloninger CR, Roache JD, Bordnick PS, Ruiz P. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population. Am J Addict. 2000;9(1):17–27.

    Article  CAS  PubMed  Google Scholar 

  38. Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles J, et al. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. 2016;2:CD009996.

    PubMed  Google Scholar 

  39. Romanos M, Reif A, Banaschewski T. Methylphenidate for attention-deficit/hyperactivity disorder. JAMA. 2016;316(9):994–5.

    Article  PubMed  Google Scholar 

  40. Huestis RD, Arnold LE, Smeltzer DJ. Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: a double-blind comparison. Am J Psychiatry. 1975;132(8):868–70.

    Article  CAS  PubMed  Google Scholar 

  41. Marmorstein NR. Energy drink and coffee consumption and psychopathology symptoms among early adolescents: cross-sectional and longitudinal associations. J Caffeine Res. 2016;6(2):64–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Aepli A, Kurth S, Tesler N, Jenni OG, Huber R. Caffeine consuming children and adolescents show altered sleep behavior and deep sleep. Brain Sci. 2015;5(4):441–55.

    Article  PubMed  PubMed Central  Google Scholar 

  43. US Food and Drug Administration. FDA to investigate added caffeine. Consumer Updates 2013 May 5.

    Google Scholar 

  44. Samsel C, Muriel AC. Risk factors and treatment for steroid-related mood and behavior symptoms in preschool children with leukemia: a case series. Pediatr Blood Cancer. 2017;64(2):343–5.

    Article  PubMed  Google Scholar 

  45. Brown ES, Woolston DJ, Frol A, Bobadilla L, Khan DA, Hanczyc M, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55(5):538–45.

    Article  CAS  PubMed  Google Scholar 

  46. Dandoy C, Gereige RS. Performance-enhancing drugs. Pediatr Rev. 2012;33(6):265.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, et al. A review of atomoxetine effects in young people with developmental disabilities. Res Dev Disabil. 2014;35(6):1412–24.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Silverman L, Hollway JA, Smith T, Aman MG, Arnold LE, Pan X, et al. A multisite trial of atomoxetine and parent training in children with autism spectrum disorders: rationale and design challenges. Res Autism Spectr Disord. 2014;8(7):899–907.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, et al. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. J Psychiatr Res. 2014;54:11–8.

    Article  PubMed  Google Scholar 

  50. Freeman D, Brugha T, Meltzer H, Jenkins R, Stahl D, Bebbington P. Persecutory ideation and insomnia: findings from the second British National Survey of Psychiatric Morbidity. J Psychiatr Res. 2010;44(15):1021–6.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Coffey C, Carlin JB, Degenhardt L, Lynskey M, Sanci L, Patton GC. Cannabis dependence in young adults: an Australian population study. Addiction. 2002;97(2):187–94.

    Article  PubMed  Google Scholar 

  52. Crowley TJ. Adolescents and substance-related disorders: research agenda to guide decisions on Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Addiction. 2006;101(s1):115–24.

    Article  PubMed  Google Scholar 

  53. Kontaxakis VP, Skourides D, Ferentinos P, Havaki-Kontaxaki BJ, Papadimitriou GN. Isotretinoin and psychopathology: a review. Ann General Psychiatry. 2009;8(1):2.

    Article  Google Scholar 

  54. Azoulay L, Blais L, Koren G, LeLorier J, Berard A. Does isotretinoin increase the risk of depression. J Clin Psychiatry. 2008;69(4):526–32.

    Article  CAS  PubMed  Google Scholar 

  55. Goodfield MJ, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, et al. Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010. Br J Dermatol. 2010;162(6):1172–9.

    Article  CAS  PubMed  Google Scholar 

  56. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004;101(26):9861–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Egunsola O, Choonara I, Sammons HM. Safety of Levetiracetam in paediatrics: a systematic review. PLoS One. 2016;11(3):e0149686.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Coccaro EF, Lawrence T, Trestman R, Gabriel S, Klar HM, Siever LJ. Growth hormone responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and healthy volunteers. Psychiatry Res. 1991;39(2):129–39.

    Article  CAS  PubMed  Google Scholar 

  59. Vucicevic J, Nikolic K, Dobričić V, Agbaba D. Prediction of blood–brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis. Eur J Pharm Sci. 2015;68:94–105.

    Article  CAS  PubMed  Google Scholar 

  60. Mohamed WM, Hamida SB, Cassel JC, de Vasconcelos AP, Jones BC. MDMA: interactions with other psychoactive drugs. Pharmacol Biochem Behav. 2011;99(4):759–74.

    Article  CAS  PubMed  Google Scholar 

  61. Vaughn MG, Salas-Wright CP, DeLisi M, Perron BE, Cordova D. Crime and violence among MDMA users in the United States. Am J Drug Alcohol Abuse. 2015;41(5):392–404.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Burstein R, Jakubowski M. Neural substrate of depression during migraine. Neurol Sci. 2009;30(S1):27–31.

    Article  Google Scholar 

  63. Barlow KM, Crawford S, Stevenson A, Sandhu SS, Belanger F, Dewey D. Epidemiology of postconcussion syndrome in pediatric mild traumatic brain injury. Pediatrics. 2010;126(2):e374–81.

    Article  PubMed  Google Scholar 

  64. Eisenberg MA, Meehan WP, Mannix R. Duration and course of post-concussive symptoms. Pediatrics. 2014;133(6):999–1006.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Albicini M, McKinlay A. A systematic review of anxiety disorders following mild, moderate and severe TBI in children and adolescents. A fresh look at anxiety disorders. Intech Open [online]. 2015;199–224.

    Google Scholar 

  66. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264–71.

    CAS  PubMed  Google Scholar 

  67. Johnson DR, Kurlan R, Leckman J, Kaplan EL. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis. 2010;50(4):481–90.

    Article  PubMed  Google Scholar 

  68. Baytunca MB, Donuk T, Erermiş S. [Evaluation of a neuropsychiatric disorder: from PANDAS to PANS and CANS]. Turk Psikiyatri Derg. 2016;27(2) [Article in Turkish].

    Google Scholar 

  69. Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002;156(4):356–61.

    Article  PubMed  Google Scholar 

  70. Suleiman J, Brilot F, Lang B, Vincent A, Dale RC. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia. 2013;54(6):1036–45.

    Article  CAS  PubMed  Google Scholar 

  71. Zuliani L, Graus F, Giometto B, Bien C, Vincent A. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry. 2012;83(6):638–45.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Konofal E, Lecendreux M, Arnulf I, Mouren MC. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004;158(12):1113–5.

    Article  PubMed  Google Scholar 

  73. Lahat E, Heyman E, Livne A, Goldman M, Berkovitch M, Zachor D. Iron deficiency in children with attention deficit hyperactivity disorder. Isr Med Assoc J. 2011;13(9):530–3.

    PubMed  Google Scholar 

  74. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004;114(1):104–8.

    Article  PubMed  Google Scholar 

  75. Patrick L. Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev. 2007;12(2):101–13.

    PubMed  Google Scholar 

  76. Kiddie JY, Weiss MD, Kitts DD, Levy-Milne R, Wasdell MB. Nutritional status of children with attention deficit hyperactivity disorder: a pilot study. Int J Pediatr. 2010;2010:767318.

    Article  PubMed  PubMed Central  Google Scholar 

  77. AC W, Lesperance L, Bernstein H. Screening for iron deficiency. Pediatr Rev. 2002;23(5):171–8.

    Article  Google Scholar 

  78. Kiddie JY, Weiss MD, Kitts DD, Levy-Milne R, Wasdell MB. Nutritional status of children with attention deficit hyperactivity disorder: a pilot study. Int J Pediatr. 2010;2010:1.

    Article  Google Scholar 

  79. Lepping P, Huber M. Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder. CNS Drugs. 2010;24(9):721–8.

    CAS  PubMed  Google Scholar 

  80. Arnold LE, Bozzolo H, Hollway J, Cook A, DiSilvestro RA, Bozzolo DR, eet a. Serum zinc correlates with parent-and teacher-rated inattention in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005;15(4):628–36.

    Article  PubMed  Google Scholar 

  81. Arnold LE, Votolato NA, Kleykamp D, Baker GB, Bornstein RA. Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci. 1990;50(1-2):103–7.

    Article  CAS  PubMed  Google Scholar 

  82. Young GP, Mortimer EK, Gopalsamy GL, Alpers DH, Binder HJ, Manary MJ, et al. Zinc deficiency in children with environmental enteropathy—development of new strategies: report from an expert workshop. Am J Clin Nutr. 2014;100(4):1198–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Rasmussen SA, Fernhoff PM, Scanlon KS. Vitamin B12 deficiency in children and adolescents. J Pediatr. 2001;138(1):10–7.

    Article  CAS  PubMed  Google Scholar 

  84. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67(2):362–70.

    Article  CAS  PubMed  Google Scholar 

  85. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4–5):329–49.

    Article  CAS  PubMed  Google Scholar 

  86. Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr. 1987;26(8):406–11.

    Article  CAS  Google Scholar 

  87. Nigg JT, Nikolas M, Mark Knottnerus G, Cavanagh K, Friderici K. Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels. J Child Psychol Psychiatry. 2010;51(1):58–65.

    Article  PubMed  Google Scholar 

  88. Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W, Rappley MD. Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biol Psychiatry. 2008;63(3):325–31.

    Article  CAS  PubMed  Google Scholar 

  89. Huang S, Hu H, Sánchez BN, Peterson KE, Ettinger AS, Lamadrid-Figueroa H, et al. Childhood blood lead levels and symptoms of attention deficit hyperactivity disorder (ADHD): a cross-sectional study of Mexican children. Environ Health Perspect. 2016;124(6):868–74.

    PubMed  Google Scholar 

  90. Tschudy MM, Arcara KM. The Harriet Lane handbook: a manual for pediatric house officers. Philadelphia: Mosby Elsevier; 2012. p. 323–4

    Google Scholar 

  91. Kumar A, Singh A. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):195–203.

    Article  CAS  PubMed  Google Scholar 

  92. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–9.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Henry JD, Phillips LH, Von Hippel C. A meta-analytic review of theory of mind difficulties in behavioural-variant frontotemporal dementia. Neuropsychologia. 2014;56:53–62.

    Article  PubMed  Google Scholar 

  94. Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry. 2013;25(2):130–7.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329–35.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Kim S, Arora M, Fernandez C, Landero J, Caruso J, Chen A. Lead, mercury, and cadmium exposure and attention deficit hyperactivity disorder in children. Environ Res. 2013;126:105–10.

    Article  CAS  PubMed  Google Scholar 

  97. DeRouen TA, Martin MD, Leroux BG, Townes BD, Woods JS, Leitão J, et al. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA. 2006;295(15):1784–92.

    Article  CAS  PubMed  Google Scholar 

  98. Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG. Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics. 2010;125(6):e1270–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Dartmouth Hitchcock Medical Center, Dartmouth Geisel School of Medicine, Lebanon, NH, USA

    John G. Ryder M.D., M.S.

  2. Department of Pediatrics, Comer Children’s Hospital, The University of Chicago, Chicago, IL, USA

    Jacquelyn M. Silva M.D.

Authors
  1. John G. Ryder M.D., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacquelyn M. Silva M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John G. Ryder M.D., M.S. .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Dartmouth Hitchcock Medical Center, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire, USA

    W. Burleson Daviss

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ryder, J.G., Silva, J.M. (2018). Mood Disturbance in ADHD Due to a General Medical Condition. In: Daviss, W. (eds) Moodiness in ADHD. Springer, Cham. https://doi.org/10.1007/978-3-319-64251-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64251-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64250-5

  • Online ISBN: 978-3-319-64251-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation